ARK Investment Management LLC
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1697748
ST. PETERSBURG, FL
Position in RXRX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$123,453,200
-$29,172,741 QoQ
Shares Held
40,212,769
+7.8% QoQ
Ownership
7.59%
of shares outstanding
% of Portfolio
0.97%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 94%
Shared 2%
None 4%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ARK Investment Management LLC holds $1,308,181,852 across 17 Biotechnology names. RXRX ranks #4 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
11,313,623 | $538,189,046 | |
| 2 | BEAM |
Beam Therapeutics Inc.
|
12,133,433 | $289,139,708 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
14,509,247 | $186,008,546 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
40,212,769 | $123,453,200 | |
| 5 | ABSI |
Absci Corp
|
13,726,169 | $41,178,507 | |
| 6 | NRIX |
Nurix Therapeutics, Inc.
|
1,721,135 | $26,677,592 | |
| 7 | PRME |
Prime Medicine, Inc.
|
6,246,827 | $21,738,957 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
288,716 | $21,679,684 |
All Filings in RXRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $123,453,200 | 40,212,769 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $152,625,941 | 37,316,856 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $163,702,035 | 33,545,499 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $166,922,472 | 32,988,631 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $184,174,005 | 34,815,502 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $218,661,650 | 32,346,398 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $215,948,935 | 32,769,186 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $211,071,885 | 28,142,918 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $245,137,983 | 24,587,561 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $203,651,269 | 20,654,287 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $52,605,974 | 6,876,598 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $35,396,721 | 4,738,517 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $23,857,669 | 3,576,862 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $23,897,067 | 3,099,490 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $35,748,389 | 3,359,811 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $22,239,188 | 2,732,087 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $20,242,487 | 2,827,163 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $38,234,382 | 2,232,013 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $59,684,166 | 2,593,836 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $86,821,637 | 2,378,675 | Shares | Sole | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||